Cavero-Redondo, Iván
Saz-Lara, Alicia
Bizzozero-Peroni, Bruno
Núñez-Martínez, Laura
Díaz-Goñi, Valentina
Calero-Paniagua, Ismael
Matínez-García, Irene
Pascual-Morena, Carlos
Article History
Received: 23 January 2024
Accepted: 4 June 2024
First Online: 18 June 2024
Declarations
:
: The ExIC-FEp trial followed the Declaration of Helsinki, was previously approved by the Clinical Research Ethics Committee of the Cuenca Health Area (REG: 2022/PI2122) and registered at ClinicalTrials.gov (NCT05726474). All participants signed the consent form.
: All study participants gave their consent to publish the results of the ExICFep trial.
: The authors declare no conflict of interest.